ANTX earnings date and last-quarter result: next report 2026-08-11, last quarter miss, P/E -4.45. Updated 2026-07-23.
AN2 Therapeutics (ANTX) Research Hub
AN2 Therapeutics (ANTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.63 USD (+2.25%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.45, market cap 0.13B. This hub links to the full technical, earnings and options research available for ANTX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.63 USD (+2.25%) |
| 52-week range | 3.22 USD – 6.37 USD |
| Trend regime | Range |
| 14-day RSI | 18.1 (Oversold) |
| Trailing P/E | -4.45 |
| Market cap | 0.13B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for ANTX
Covered Call on ANTX: how it works, illustrative setup around the real 3.63 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ANTX: how it works, illustrative setup around the real 3.63 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ANTX: how it works, illustrative setup around the real 3.63 USD price, max profit/loss, breakeven and when to use it. Educational.
ANTX technical analysis: range, last 3.63 USD, RSI 18.1, 52w range 3.22 USD–6.37 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ANTX in?
AN2 Therapeutics (ANTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ANTX in an uptrend or downtrend?
As of 2026-10-26, ANTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ANTX's trailing P/E ratio?
ANTX's trailing P/E is -4.45, with a market cap of 0.13B. See the earnings research page for full valuation detail.
When does ANTX next report earnings?
ANTX is next scheduled to report earnings on 2026-08-11.